bf/NASDAQ:GLSI_icon.png

NASDAQ:GLSI

Greenwich LifeSciences, Inc.

  • Stock

9.98

−1.19%

−1.27

USD last updated 31/07 01:47:08

Last Close

11.25

30/07 20:00

Market Cap

203.12M

Beta: 3.53

Volume Today

23.73K

Avg: 47.81K

PE Ratio

−13.47

PFCF: −17.98

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1-0.8-0.6-0.4-0.22019-03-312020-06-302022-05-202024-03-292024-10-17

    Revenue (Estimate*)

    0.000.000.010.010.012019-03-312020-06-302022-05-202024-03-292024-10-17

    *Estimate based on analyst consensus